1. Home
  2. CGTX vs CLAR Comparison

CGTX vs CLAR Comparison

Compare CGTX & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • CLAR
  • Stock Information
  • Founded
  • CGTX 2007
  • CLAR 1957
  • Country
  • CGTX United States
  • CLAR United States
  • Employees
  • CGTX N/A
  • CLAR N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • CLAR Recreational Games/Products/Toys
  • Sector
  • CGTX Health Care
  • CLAR Consumer Discretionary
  • Exchange
  • CGTX Nasdaq
  • CLAR Nasdaq
  • Market Cap
  • CGTX 126.2M
  • CLAR 139.4M
  • IPO Year
  • CGTX 2021
  • CLAR N/A
  • Fundamental
  • Price
  • CGTX $1.70
  • CLAR $3.28
  • Analyst Decision
  • CGTX Strong Buy
  • CLAR Strong Buy
  • Analyst Count
  • CGTX 3
  • CLAR 3
  • Target Price
  • CGTX $2.83
  • CLAR $5.33
  • AVG Volume (30 Days)
  • CGTX 3.3M
  • CLAR 101.2K
  • Earning Date
  • CGTX 11-12-2025
  • CLAR 11-06-2025
  • Dividend Yield
  • CGTX N/A
  • CLAR 3.06%
  • EPS Growth
  • CGTX N/A
  • CLAR N/A
  • EPS
  • CGTX N/A
  • CLAR N/A
  • Revenue
  • CGTX N/A
  • CLAR $254,200,000.00
  • Revenue This Year
  • CGTX N/A
  • CLAR N/A
  • Revenue Next Year
  • CGTX N/A
  • CLAR $4.38
  • P/E Ratio
  • CGTX N/A
  • CLAR N/A
  • Revenue Growth
  • CGTX N/A
  • CLAR N/A
  • 52 Week Low
  • CGTX $0.22
  • CLAR $3.02
  • 52 Week High
  • CGTX $3.83
  • CLAR $5.29
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 52.47
  • CLAR 34.02
  • Support Level
  • CGTX $1.29
  • CLAR $3.43
  • Resistance Level
  • CGTX $1.61
  • CLAR $3.80
  • Average True Range (ATR)
  • CGTX 0.14
  • CLAR 0.15
  • MACD
  • CGTX -0.01
  • CLAR -0.05
  • Stochastic Oscillator
  • CGTX 93.62
  • CLAR 4.57

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: